全文获取类型
收费全文 | 29749篇 |
免费 | 1878篇 |
国内免费 | 184篇 |
专业分类
耳鼻咽喉 | 348篇 |
儿科学 | 734篇 |
妇产科学 | 529篇 |
基础医学 | 3628篇 |
口腔科学 | 1058篇 |
临床医学 | 2530篇 |
内科学 | 7451篇 |
皮肤病学 | 670篇 |
神经病学 | 2497篇 |
特种医学 | 936篇 |
外科学 | 4976篇 |
综合类 | 149篇 |
一般理论 | 9篇 |
预防医学 | 1711篇 |
眼科学 | 696篇 |
药学 | 1510篇 |
1篇 | |
中国医学 | 53篇 |
肿瘤学 | 2325篇 |
出版年
2023年 | 257篇 |
2022年 | 421篇 |
2021年 | 1123篇 |
2020年 | 569篇 |
2019年 | 924篇 |
2018年 | 1141篇 |
2017年 | 691篇 |
2016年 | 753篇 |
2015年 | 907篇 |
2014年 | 1213篇 |
2013年 | 1465篇 |
2012年 | 2363篇 |
2011年 | 2486篇 |
2010年 | 1345篇 |
2009年 | 1234篇 |
2008年 | 1982篇 |
2007年 | 2027篇 |
2006年 | 1863篇 |
2005年 | 1722篇 |
2004年 | 1512篇 |
2003年 | 1301篇 |
2002年 | 1157篇 |
2001年 | 270篇 |
2000年 | 223篇 |
1999年 | 260篇 |
1998年 | 250篇 |
1997年 | 200篇 |
1996年 | 171篇 |
1995年 | 174篇 |
1994年 | 149篇 |
1993年 | 149篇 |
1992年 | 144篇 |
1991年 | 106篇 |
1990年 | 90篇 |
1989年 | 91篇 |
1988年 | 83篇 |
1987年 | 72篇 |
1986年 | 78篇 |
1985年 | 61篇 |
1984年 | 75篇 |
1983年 | 70篇 |
1982年 | 76篇 |
1981年 | 67篇 |
1980年 | 49篇 |
1979年 | 47篇 |
1978年 | 39篇 |
1977年 | 46篇 |
1975年 | 33篇 |
1974年 | 33篇 |
1973年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
Noreen M. Walsh Heinz Kutzner Luis Requena Lorenzo Cerroni 《Journal of cutaneous pathology》2019,46(9):698-708
We review the spectrum of cutaneous disorders associated with inflammatory and neoplastic plasmacytic pathology. Because plasma cells are derived from B‐lymphocytes our overview includes discussion of certain lymphoplasmacytic proliferations. It is structured along histopathological lines, addressing conditions characterized by (a) cutaneous plasma cell infiltrates, (b) deposits of plasma cell products or their derivatives in the skin and (c) miscellaneous, poorly understood cutaneous complications of plasmacytic disorders. Lesions arising primarily in the skin and those due to cutaneous involvement by multisystem disorders are addressed. The range includes a spectrum of tumefactive and circulatory manifestations. We highlight key clinical and pathological features of the different conditions and outline recent advances in our understanding of these entities. By emphasizing the dermatopathological characteristics of this spectrum of disorders we hope to hone the diagnostic accuracy of practitioners in the field. 相似文献
2.
3.
4.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
5.
6.
7.
Cost‐Effectiveness and Cost‐Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study 下载免费PDF全文
Furio Zucco MD Roberta Ciampichini MSc Angelo Lavano MD Amedeo Costantini MD Marisa De Rose MD Paolo Poli MD Gianpaolo Fortini MD Laura Demartini MD Enrico De Simone MD Valentino Menardo MD Piero Cisotto MD Mario Meglio MD Luciana Scalone PhD Lorenzo G. Mantovani DSc 《Neuromodulation》2015,18(4):266-276
8.
9.
10.
Iria Montero Prez Laura Rodríguez‐Pazos Adriana lvarez‐Prez MªMercedes Pereiro Ferreirs Carlos Aliste Jose Manuel Suarez‐Pearanda Jaime Toribio 《Journal of cutaneous pathology》2015,42(11):889-893
Classical Kaposi sarcoma (KS) usually appears on lower extremities accompanied or preceded by local lymphedema. However, the development in areas of chronic lymphedema of the arms following mastectomy, mimicking a Stewart–Treves syndrome, has rarely been described. We report an 81‐year‐old woman who developed multiple, erythematous to purple tumors, located on areas of post mastectomy lymphedema. Histopathological examination evidenced several dermal nodules formed by spindle‐shaped cells that delimitated slit‐like vascular spaces with some red cell extravasation. Immunohistochemically, the human herpesvirus type 8 (HHV‐8) latent nuclear antigen‐1 was detected in the nuclei of most tumoral cells confirming the diagnosis of KS. Lymphedema could promote the development of certain tumors by altering immunocompetence. Although angiosarcoma (AS) is the most frequent neoplasia arising in the setting of chronic lymphedema, other tumors such as benign lymphangiomatous papules (BLAP) or KS can also develop in lymphedematous limbs. It is important to establish the difference between AS and KS because their prognosis and treatment are very different. Identification by immunohistochemistry of HHV‐8 is useful for the distinction between KS and AS or BLAP. 相似文献